Most Effective Weight Loss Medication

Featured Article

This is a randomized, double-blind, placebo-controlled study to determine the safety, tolerability, and effectiveness of subcutaneous injections of the weight-loss medication AC2307 (davalintide). This Phase II clinical trial is currently recruiting patients between the ages of 18 and 65 who have a BMI over 27.

Read more

More information on "Most Effective Weight Loss Medication"

From Our Experts

See more SharePosts »

From Our Sources

More on Diet & Exercise »